Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists
Open Access
- 1 September 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 112 (5), 1750-1758
- https://doi.org/10.1182/blood-2008-01-130500
Abstract
Neonates exhibit an increased risk of sepsis mortality compared with adults. We show that in contrast to adults, survival from polymicrobial sepsis in murine neonates does not depend on an intact adaptive immune system and is not improved by T cell–directed adaptive immunotherapy. Furthermore, neonates manifest an attenuated inflammatory and innate response to sepsis, and have functional defects in their peritoneal CD11b+ cells. Activation of innate immunity with either a Toll-like receptor 4 (TLR4) or TLR7/8 agonist, but not a TLR3 agonist, increased the magnitude, but abbreviated the early systemic inflammatory response, reduced bacteremia, and improved survival to polymicrobial sepsis. TLR4 agonist pretreatment enhanced peritoneal neutrophil recruitment with increased oxidative burst production, whereas the TLR7/8 agonist also enhanced peritoneal neutrophil recruitment with increased phagocytic ability. These benefits were independent of the adaptive immune system and type I interferon signaling. Improving innate immune function with select TLR agonists may be a useful strategy to prevent neonatal sepsis mortality.This publication has 52 references indexed in Scilit:
- Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsisBlood, 2007
- Adaptive immune cells temper initial innate responsesNature Medicine, 2007
- MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsisThe Journal of Experimental Medicine, 2007
- Type I interferons protect neonates from acute inflammation through interleukin 10–producing B cellsThe Journal of Experimental Medicine, 2007
- Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cellsBlood, 2006
- ACTIVATION OF COMMON ANTIVIRAL PATHWAYS CAN POTENTIATE INFLAMMATORY RESPONSES TO SEPTIC SHOCKShock, 2006
- Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27The Journal of Experimental Medicine, 2006
- Pathogen Recognition and Innate ImmunityCell, 2006
- Type I interferon dependence of plasmacytoid dendritic cell activation and migrationThe Journal of Experimental Medicine, 2005
- Notch–RBP-J signaling is involved in cell fate determination of marginal zone B cellsNature Immunology, 2002